SIGN IN
SCIENTIST, FORMULATION AND DP DEVELOPMENT jobs in United States
cer-icon
Apply on Employer Site
company-logo

Sutro Biopharma, Inc. · 6 hours ago

SCIENTIST, FORMULATION AND DP DEVELOPMENT

Sutro Biopharma, Inc. is looking for a technical leader for their Formulation and DP Development team. The role involves developing new compositions for biologic and conjugated molecules, participating in formulation and DP development, and engaging in technology transfer to CMOs.
BiotechnologyHealthcareInformation TechnologyMedical
check
Growth Opportunities
check
H1B Sponsor Likelynote

Responsibilities

Work within our Formulation and DP Development team to participate in formulation and DP development for phase appropriate liquid and lyophilized formulations for intermediates, drug substance and drug products
Participate in activities in technology transfer to CMO’s
Design, execute, document formulation and stability studies and other experiments to support the robustness and validity of final formulation and lyo cycle parameters
Utilize/implement fit-for-purpose analytical methods for biophysical characterization, formulation and process development and stability testing
Communicate experimental data both verbally at group, department and cross functional meetings and through written documents and reports that may be included in regulatory filings

Qualification

Formulation developmentLyophilization expertiseAnalytical method developmentBiophysical characterizationCGMP knowledgeScientific creativityCommunicationCollaboration skillsDetail-oriented

Required

BS/MS (6-8+ years) or PhD (1-6+ years) of experience in scientific discipline (Pharmaceutical Sciences, Chemistry, Chemical Engineering, Biomedical Engineering, or related discipline) and demonstrated scientific creativity and contributions
Hands-on experience and proficiency with pilot scale or commercial lyophilizers, lyo cycle development/optimization, knowledge of software
Solid technical skills and experience in pre-formulation screening studies, biophysical/ biochemical characterization of proteins, analytical method development and protein/ antibody/ADC product development is essential
Demonstrated ability to design experiments and routinely generate new ideas and original research. High level of scientific initiative and independence. May undertake collaborations with other disciplines. Highly autonomous requiring minimal supervision from manager
Analytical instrumentation such as chromatographic (HPLC, UPLC, column chromatography), visible and subvisible particle analysis, capillary electrophoresis and/or biophysical techniques (UV-vis, MALS/DLS, DSC, CD, FTIR, AUC, Fluorescence spectroscopy) for protein characterization are highly desirable
Able to cooperate effectively with cross functional teams, such as up and down stream process development, manufacturing and quality. Ability to quickly adapt to changes in project direction
Working knowledge of cGMP and relevant drug product development guidelines and regulations
Flexibility to work on multiple projects between departments in a fast-paced environment is essential
Excellent oral and written communication skills and being detailed oriented are important attributes

Company

Sutro Biopharma, Inc.

twittertwittertwitter
company-logo
Sutro Biopharma, Inc., is relentlessly focused on the discovery and development of precisely designed cancer therapeutics to transform what science can do for patients.

H1B Sponsorship

Sutro Biopharma, Inc. has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (6)
2024 (6)
2023 (7)
2022 (2)
2021 (3)
2020 (2)

Funding

Current Stage
Public Company
Total Funding
$636.61M
Key Investors
Blackstone Life SciencesSamsara BioCapital,Surveyor CapitalSkyline Ventures
2024-04-02Post Ipo Equity· $75M
2023-06-26Post Ipo Debt· $140M
2020-12-14Post Ipo Equity· $144.9M

Leadership Team

leader-logo
Henry Heinsohn
VP Process Development
linkedin
leader-logo
Barbara Leyman
Chief Business Officer
linkedin
Company data provided by crunchbase